DalsnaFinance

Cantor Fitzgerald raises Abbvie stock price target to $265 on biopharma outlook

Markets Investing.com By Investing.com 06 Jul 2026 11:34 1 min read
Cantor Fitzgerald raises Abbvie stock price target to $265 on biopharma outlook

Cantor Fitzgerald raises Abbvie stock price target to $265 on biopharma outlook

Cantor Fitzgerald raises Abbvie stock price target to $265 on biopharma outlook

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.